Life Science Investing Clearmind Medicine Enrolls Last Patient for the First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
Life Science Investing Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders
Life Science Investing Clearmind Medicine's Convenes Inaugural Scientific Advisory Board Meeting to Advance Psychedelic-Derived Therapies
Life Science Investing Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities
